BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1680 related articles for article (PubMed ID: 28396101)

  • 1. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
    Adil A; Godwin M
    J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
    Gupta AK; Mays RR; Dotzert MS; Versteeg SG; Shear NH; Piguet V
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2112-2125. PubMed ID: 29797431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the treatment of male pattern hair loss.
    York K; Meah N; Bhoyrul B; Sinclair R
    Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgenetic alopecia: an evidence-based treatment update.
    Varothai S; Bergfeld WF
    Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's New in Therapy for Male Androgenetic Alopecia?
    Saceda-Corralo D; Domínguez-Santas M; Vañó-Galván S; Grimalt R
    Am J Clin Dermatol; 2023 Jan; 24(1):15-24. PubMed ID: 36169916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dutasteride in Androgenetic Alopecia: An Update.
    Arif T; Dorjay K; Adil M; Sami M
    Curr Clin Pharmacol; 2017; 12(1):31-35. PubMed ID: 28294070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment of evidence quality.
    Gupta AK; Bamimore MA; Foley KA
    J Dermatolog Treat; 2022 Feb; 33(1):62-72. PubMed ID: 32250713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of combination therapies for androgenetic alopecia: A systematic review and meta-analysis.
    Zhou Y; Chen C; Qu Q; Zhang C; Wang J; Fan Z; Miao Y; Hu Z
    Dermatol Ther; 2020 Jul; 33(4):e13741. PubMed ID: 32478968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of combinational therapy using topical minoxidil and microneedling for the treatment of androgenetic alopecia: a systematic review and meta-analysis.
    Abdi P; Awad C; Anthony MR; Farkouh C; Kenny B; Maibach HI; Ogunyemi B
    Arch Dermatol Res; 2023 Dec; 315(10):2775-2785. PubMed ID: 37665358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
    Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
    J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive Hair Rejuvenation.
    Sand J; Walen S
    Clin Plast Surg; 2023 Jul; 50(3):509-520. PubMed ID: 37169416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive Hair Rejuvenation.
    Sand J; Walen S
    Facial Plast Surg Clin North Am; 2022 Aug; 30(3):419-431. PubMed ID: 35934443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis.
    Chen L; Zhang J; Wang L; Wang H; Chen B
    Aesthetic Plast Surg; 2020 Jun; 44(3):962-970. PubMed ID: 32166351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
    Nestor MS; Ablon G; Gade A; Han H; Fischer DL
    J Cosmet Dermatol; 2021 Dec; 20(12):3759-3781. PubMed ID: 34741573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil
    Gentile P; Garcovich S
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia.
    Faghihi G; Mozafarpoor S; Asilian A; Mokhtari F; Esfahani AA; Bafandeh B; Nouraei S; Nilforoushzadeh MA; Hosseini SM
    Indian J Dermatol Venereol Leprol; 2018; 84(5):547-553. PubMed ID: 30027912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of androgenetic alopecia.
    Bolduc C; Shapiro J
    Am J Clin Dermatol; 2000; 1(3):151-8. PubMed ID: 11702296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review.
    Mella JM; Perret MC; Manzotti M; Catalano HN; Guyatt G
    Arch Dermatol; 2010 Oct; 146(10):1141-50. PubMed ID: 20956649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo-controlled dose-effect studies with topical minoxidil 2% or 5% in male-patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol.
    Van Neste D
    Skin Res Technol; 2020 Jul; 26(4):542-557. PubMed ID: 31957152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.